» Articles » PMID: 32699618

Risk Factors for Non-diabetic Renal Disease in Diabetic Patients

Abstract

Background: Diabetic patients with kidney disease have a high prevalence of non-diabetic renal disease (NDRD). Renal and patient survival regarding the diagnosis of diabetic nephropathy (DN) or NDRD have not been widely studied. The aim of our study is to evaluate the prevalence of NDRD in patients with diabetes and to determine the capacity of clinical and analytical data in the prediction of NDRD. In addition, we will study renal and patient prognosis according to the renal biopsy findings in patients with diabetes.

Methods: Retrospective multicentre observational study of renal biopsies performed in patients with diabetes from 2002 to 2014.

Results: In total, 832 patients were included: 621 men (74.6%), mean age of 61.7 ± 12.8 years, creatinine was 2.8 ± 2.2 mg/dL and proteinuria 2.7 (interquartile range: 1.2-5.4) g/24 h. About 39.5% ( = 329) of patients had DN, 49.6% ( = 413) NDRD and 10.8% ( = 90) mixed forms. The most frequent NDRD was nephroangiosclerosis (NAS) ( = 87, 9.3%). In the multivariate logistic regression analysis, older age [odds ratio (OR) = 1.03, 95% CI: 1.02-1.05, P < 0.001], microhaematuria (OR = 1.51, 95% CI: 1.03-2.21, P = 0.033) and absence of diabetic retinopathy (DR) (OR = 0.28, 95% CI: 0.19-0.42, P < 0.001) were independently associated with NDRD. Kaplan-Meier analysis showed that patients with DN or mixed forms presented worse renal prognosis than NDRD (P < 0.001) and higher mortality (P = 0.029). In multivariate Cox analyses, older age (P < 0.001), higher serum creatinine (P < 0.001), higher proteinuria (P < 0.001), DR (P = 0.007) and DN (P < 0.001) were independent risk factors for renal replacement therapy. In addition, older age (P < 0.001), peripheral vascular disease (P = 0.002), higher creatinine (P = 0.01) and DN (P = 0.015) were independent risk factors for mortality.

Conclusions: The most frequent cause of NDRD is NAS. Elderly patients with microhaematuria and the absence of DR are the ones at risk for NDRD. Patients with DN presented worse renal prognosis and higher mortality than those with NDRD. These results suggest that in some patients with diabetes, kidney biopsy may be useful for an accurate renal diagnosis and subsequently treatment and prognosis.

Citing Articles

Cohort profile: the PRIMETIME 1 (PRecIsion MEdicine based on kidney TIssue Molecular interrogation in diabetic nEphropathy) cohort - a longitudinal Danish nationwide study of individuals with diabetes and a performed kidney biopsy.

Jensen K, Kosjerina V, Hansen D, Persson F, Bressendorff I, Moller M BMJ Open. 2024; 14(9):e086086.

PMID: 39306356 PMC: 11535715. DOI: 10.1136/bmjopen-2024-086086.


The role of kidney biopsy in deciphering diabetic versus non-diabetic origin of kidney disease among patients with type 2 diabetes mellitus and nephrotic range proteinuria: A retrospective study.

Kardalas E, Paikopoulou A, Vassiliadi D, Kounatidis D, Vallianou N, Vourlakou C Metabol Open. 2024; 23:100313.

PMID: 39282240 PMC: 11402212. DOI: 10.1016/j.metop.2024.100313.


Correlation between retinal vascular geometric parameters and pathologically diagnosed type 2 diabetic nephropathy.

Liu F, Chen X, Wang Q, Lin W, Li Y, Zhang R Clin Kidney J. 2024; 17(8):sfae204.

PMID: 39099565 PMC: 11292218. DOI: 10.1093/ckj/sfae204.


What Not to Overlook in the Management of Patients with Type 2 Diabetes Mellitus: The Nephrological and Hepatological Perspectives.

Alfieri C, Molinari P, Cinque F, Vettoretti S, Cespiati A, Bignamini D Int J Mol Sci. 2024; 25(14).

PMID: 39062970 PMC: 11276657. DOI: 10.3390/ijms25147728.


Kidney Histopathology of Patients with Hepatitis C Infection and Diabetes Mellitus before and after Availability of Direct-Acting Antiviral Therapy.

Kung V, Giannini G, Nast C Glomerular Dis. 2024; 4(1):74-83.

PMID: 38623264 PMC: 11018331. DOI: 10.1159/000537977.


References
1.
Afkarian M, Sachs M, Kestenbaum B, Hirsch I, Tuttle K, Himmelfarb J . Kidney disease and increased mortality risk in type 2 diabetes. J Am Soc Nephrol. 2013; 24(2):302-8. PMC: 3559486. DOI: 10.1681/ASN.2012070718. View

2.
. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018; 392(10159):1789-1858. PMC: 6227754. DOI: 10.1016/S0140-6736(18)32279-7. View

3.
Zhuo L, Zou G, Li W, Lu J, Ren W . Prevalence of diabetic nephropathy complicating non-diabetic renal disease among Chinese patients with type 2 diabetes mellitus. Eur J Med Res. 2013; 18:4. PMC: 3598553. DOI: 10.1186/2047-783X-18-4. View

4.
Imtiaz S, Drohlia M, Nasir K, Salman B, Ahmad A . Analysis of renal diseases detected in renal biopsies of adult patients: A single-center experience. Saudi J Kidney Dis Transpl. 2017; 28(2):368-378. DOI: 10.4103/1319-2442.202788. View

5.
Mazzucco G, Bertani T, Fortunato M, Bernardi M, Leutner M, Boldorini R . Different patterns of renal damage in type 2 diabetes mellitus: a multicentric study on 393 biopsies. Am J Kidney Dis. 2002; 39(4):713-20. DOI: 10.1053/ajkd.2002.31988. View